Evidence map›Paper›PMID 28293406›Full record

ReviewMediterranean journal of hematology and infectious diseases2017

β-Thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical Standpoint.

Vincenzo De Sanctis, Christos Kattamis, Duran Canatan, Ashraf T Soliman, Heba Elsedfy, Mehran Karimi, Shahina Daar, Yasser Wali, Mohamed Yassin, Nada Soliman and 5 more

Open access · goldAbstract readReview
In one paragraph

Review in Mediterranean journal of hematology and infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 128 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
128citing papers in PubMed, 6 pooled it
12.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

128 citing papers in PubMed, 6 syntheses or guidelines pooled it, 267 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Ancient DNA and Human Physiology.Physiology (Bethesda, Md.) · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Expression of Immune CheckpointsTurkish journal of haematology : official journal of Turkish Society of Haematology · 2026
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

68 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Vincenzo De SanctisPediatric and Adolescent Outpatient Clinic, Quisisana Hospital, Ferrara, Italy.
Christos KattamisFirst Department of Paediatrics, University of Athens, Athens, Greece.
Duran CanatanDirector of Thalassemia Diagnosis Center of Mediterranean Blood Diseases Foundation, Antalya, Turkey.
Ashraf T SolimanDepartment of Pediatrics, Division of Endocrinology, Alexandria University Children's Hospital, Alexandria, Egypt.
Heba ElsedfyDepartment of Pediatrics, Ain Shams University, Cairo, Egypt.
Mehran KarimiHematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Shahina DaarDepartment of Haematology, College of Medicine and Health Sciences, Sultan Qaboos University, Sultanate of Oman.
Yasser WaliPediatric Hematology Unit, Child Health Department, Sultan Qaboos University Hospital, Muscat, Oman and Department of Pediatrics, Alexandria University Children's Hospital, Egypt.
Mohamed YassinNational Center for Cancer Care and Research, Medical Oncology Hematology Section HMC, Doha, Qatar.
Nada SolimanPrimary Health Care, Ministry of Health, Alexandria, Egypt.
Praveen SobtiProfessor, Pediatric Hemato-Oncology, Christian Medical College and Hospital, Ludhiana, Punjab, India.
Soad Al JaouniHead, Division of Pediatric Hematology Oncology, Deputy Chair of Hematology and Head, Section of Hematology Research Lab, King Fahd Medical Research Center, Department of Hematology Faculty of Medicine, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
Mohamed El KholyDepartment of Pediatrics, Ain Shams University, Cairo, Egypt.
Bernadette FiscinaDepartment of Pediatrics, NYU School of Medicine, New York, USA.
Michael AngastiniotisMedical Advisor, Thalassemia International Federation (TIF), Nicosia, Cyprus.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHaemoglobinopathies constitute the commonest recessive monogenic disorders worldwide, and the treatment of affected individuals presents a substantial global disease burden. β-thalassaemia is characterised by the reduced synthesis (β

aimThe principal aim of this paper is to review, from a historical standpoint, our knowledge about an ancient disease, the β-thalassemias, and in particular, when, how and in what way β-thalassemia spread worldwide to reach such high incidences in certain populations.

resultsMutations involving the β-globin gene are the most common cause of genetic disorders in humans. To date, more than 350 β-thalassaemia mutations have been reported. Considering the current distribution of β- thalassemia, the wide diversity of mutations and the small number of specific mutations in individual populations, it seems unlikely that β-thalassemia originated in a single place and time.

conclusionsVarious processes are known to determine the frequency of genetic disease in human populations. However, it is almost impossible to decide to what extent each process is responsible for the presence of a particular genetic disease. The wide spectrum of β-thalassemia mutations could well be explained by looking at their geographical distribution, the history of malaria, wars, invasions, mass migrations, consanguinity, and settlements. An analysis of the distribution of the molecular spectrum of haemoglobinopathies allows for the development and improvement of diagnostic tests and management of these disorders.

Indexed as

Ancient diseaseOld WorldThalassemia distribution

Identifiers

PMID28293406
PMCPMC5333734
OpenAlexW2589779391

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.